Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6

Tohoku Journal of Experimental Medicine

Volumn 233, Issue 3, 2014, Pages 175-182

  Li, Xinyi ^a   Wang, Yanfu ^a   Han, Chao ^a   Li, Pai ^a   Zhang, Hua ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Colorectal cancer; Interleukin 17; Interleukin 6; T helper 17 cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; IL17A PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; TH17 CELL; TUMOR IMMUNITY; BLOOD; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; MONONUCLEAR CELL; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOGENESIS; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; TH17 CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904676840     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.233.175     Document Type: Article

References (35)

1. Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. (2007) Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol., 8, 942-949.
2. Annunziato, F., Cosmi, L., Liotta, F., Maggi, E. & Romagnani, S. (2013) Main features of human T helper 17 cells. Ann. NY Acad. Sci., 1284, 66-70.
3. Becker, C., Fantini, M.C., Wirtz, S., Nikolaev, A., Lehr, H.A., Galle, P.R., Rose-John, S. & Neurath, M.F. (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle, 4, 217-220.
4. Cesari, M., Penninx, B.W., Pahor, M., Lauretani, F., Corsi, A.M., Rhys Williams, G., Guralnik, J.M. & Ferrucci, L. (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J. Gerontol. A Biol. Sci. Med. Sci., 59, 242-248.
5. Cevenini, E., Monti, D. & Franceschi, C. (2013) Inflamm-ageing. Curr. Opin. Clin. Nutr. Metab. Care, 16, 14-20.
6. Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B. & Chen, Z. (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer, 69, 348-354.
7. Coussens, L.M. & Werb, Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
8. De Martinis, M., Franceschi, C., Monti, D. & Ginaldi, L. (2005) Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett., 579, 2035-2039.
9. Erdman, S.E. & Poutahidis, T. (2010) Roles for inflammation and regulatory T cells in colon cancer. Toxicol. Pathol., 38, 76-87.
10. Gaffen, S.L. (2008) An overview of IL-17 function and signaling. Cytokine, 43, 402-407.
11. Jang, J.W., Oh, B.S., Kwon, J.H., You, C.R., Chung, K.W., Kay, C.S. & Jung, H.S. (2012) Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine, 60, 686-693.
12. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. & Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
13. Knupfer, H. & Preiss, R. (2010) Serum interleukin-6 levels in colorectal cancer patients: a summary of published results. Int. J. Colorectal Dis., 25, 135-140.
14. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. (2009) IL-17 and Th17 Cells. Annu. Rev. Immunol., 27, 485-517.
15. Lakatos, P.L. & Lakatos, L. (2008) Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol., 14, 3937-3947.
16. Liu, J., Duan, Y., Cheng, X., Chen, X., Xie, W., Long, H., Lin, Z. & Zhu, B. (2011) IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem. Biophys. Res. Commun., 407, 348-354.
17. Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X.O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N.P., Overwijk, W.W. & Dong, C. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 31, 787-798.
18. Miossec, P., Korn, T. & Kuchroo, V.K. (2009) Interleukin-17 and type 17 helper T cells. N. Engl. J. Med., 361, 888-898.
19. Miyahara, Y., Odunsi, K., Chen, W., Peng, G., Matsuzaki, J. & Wang, R.F. (2008) Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA, 105, 15505-15510.
20. Monteleone, G., Pallone, F. & Stolfi, C. (2012) The dual role of inflammation in colon carcinogenesis. Int. J. Mol. Sci., 13, 11071-11084.
21. Muranski, P., Boni, A., Antony, P.A., Cassard, L., Irvine, K.R., Kaiser, A., Paulos, C.M., Palmer, D.C., Touloukian, C.E., Ptak, K., Gattinoni, L., Wrzesinski, C., Hinrichs, C.S., Kerstann, K.W., Feigenbaum, L., et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood, 112, 362-373.
22. Neurath, M.F. & Finotto, S. (2011) IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev., 22, 83-89.
23. Numasaki, M., Fukushi, J., Ono, M., Narula, S.K., Zavodny, P.J., Kudo, T., Robbins, P.D., Tahara, H. & Lotze, M.T. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101, 2620-2627.
24. Pawelec, G., Derhovanessian, E. & Larbi, A. (2010) Immunosenescence and cancer. Crit. Rev. Oncol. Hematol., 75, 165-172.
25. Schneider, M.R., Hoeflich, A., Fischer, J.R., Wolf, E., Sordat, B. & Lahm, H. (2000) Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett., 151, 31-38.
26. Sfanos, K.S., Bruno, T.C., Maris, C.H., Xu, L., Thoburn, C.J., DeMarzo, A.M., Meeker, A.K., Isaacs, W.B. & Drake, C.G. (2008) Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res., 14, 3254-3261.
27. Shacter, E. & Weitzman, S.A. (2002) Chronic inflammation and cancer. Oncology (Williston Park), 16, 217-226, 229; discussion 230-232.
28. Stephen, B.E. (2010) Colon and rectum AJCC Cancer Staging Manual. In AJCC Cancer Staging Manual, 7th ed., edited by Edge, S.B., Bird, D.R., Compton, C.C., Fritz, A.G., Greene, F.L. & Trotti, A. Springer, Berlin, pp. 143-164.
29. Terzić, J., Grivennikov, S., Karin, E. & Karin, M. (2010) Inflammation and colon cancer. Gastroenterology, 138, 2101-2114.
30. Tesmer, L.A., Lundy, S.K., Sarkar, S. & Fox, D.A. (2008) Th17 cells in human disease. Immunol. Rev., 223, 87-113.
31. Wang, L., Yi, T., Kortylewski, M., Pardoll, D.M., Zeng, D. & Yu, H. (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med., 206, 1457-1464.
32. Wilke, C.M., Kryczek, I., Wei, S., Zhao, E., Wu, K., Wang, G. & Zou, W. (2011) Th17 cells in cancer: help or hindrance? Carcinogenesis, 32, 643-649.
33. Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., Housseau, F., Pardoll, D.M. & Sears, C.L. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med., 15, 1016-1022.
34. Zhang, B., Rong, G., Wei, H., Zhang, M., Bi, J., Ma, L., Xue, X., Wei, G., Liu, X. & Fang, G. (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun., 374, 533-537.
35. Zhang, J.P., Yan, J., Xu, J., Pang, X.H., Chen, M.S., Li, L., Wu, C., Li, S.P. & Zheng, L. (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol., 50, 980-989.